An Improved Standard of Care for the Treatment of Ear Infections
Your Subtitle text
Medical advisory board
Dr. Gerald Healy, MD
Gerald Healy is the chairman of EntraTympanic’s Medical Advisory Board. Dr. Healy is Professor of Otology & Laryngology at the Harvard Medical School and is the former President of the American College of Surgeons. He is Otolaryngologist-in-Chief (Emeritus) and Surgeon-in-Chief (Emeritus) at Children’s Hospital in Boston.
Dr. Healy is a member of numerous honorary societies, including the American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, the Triological Society, the American Laryngological Association, the American Society of Pediatric Otolaryngology and the American Society of Head and Neck Surgery. He has served as President of the Massachusetts Chapter of the American College of Surgeons, the American Society of Pediatric Otolaryngology, the American Bronchoesophageal Association, and the Triological Society (the leading academic society in the specialty of Otolaryngology-Head and Neck Surgery). He has served as Secretary and President of the American Laryngological Association. He is an Honorary Fellow of the Royal College of Surgeons of Ireland and the Royal College of Surgeons of England. He has served as a Chairman of the Board of Regents of the American College of Surgeons and is the immediate past-President of the American College. He was the first Otolaryngologist to be elected President.
Gerald Healy is the chairman of EntraTympanic’s Medical Advisory Board. Dr. Healy is Professor of Otology & Laryngology at the Harvard Medical School and is the former President of the American College of Surgeons. He is Otolaryngologist-in-Chief (Emeritus) and Surgeon-in-Chief (Emeritus) at Children’s Hospital in Boston.
Dr. Healy is a member of numerous honorary societies, including the American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, the Triological Society, the American Laryngological Association, the American Society of Pediatric Otolaryngology and the American Society of Head and Neck Surgery. He has served as President of the Massachusetts Chapter of the American College of Surgeons, the American Society of Pediatric Otolaryngology, the American Bronchoesophageal Association, and the Triological Society (the leading academic society in the specialty of Otolaryngology-Head and Neck Surgery). He has served as Secretary and President of the American Laryngological Association. He is an Honorary Fellow of the Royal College of Surgeons of Ireland and the Royal College of Surgeons of England. He has served as a Chairman of the Board of Regents of the American College of Surgeons and is the immediate past-President of the American College. He was the first Otolaryngologist to be elected President.
Dr. Dennis S. Poe, MD
Dennis Poe is a member of EntraTympanic’s Medical Advisory Board. He is an Associate Professor in the Department of Otology and Laryngology at Harvard Medical School and an Associate in Otolaryngology at Children's Hospital in Boston. He is a neurotologic and skull base surgeon who has pioneered minimally invasive techniques in this field and developed new procedures for Eustachian tube disorders. His research activities focus on otitis media and novel therapies for sensorineural hearing loss. He is investigating the inflammatory basis of Eustachian tube dysfunction and doing research in collaboration with the University of Tampere, Finland and the NanoEar European Union consortium on nanotechnology for targeted delivery of inner ear and middle ear therapy.
Dennis Poe is a member of EntraTympanic’s Medical Advisory Board. He is an Associate Professor in the Department of Otology and Laryngology at Harvard Medical School and an Associate in Otolaryngology at Children's Hospital in Boston. He is a neurotologic and skull base surgeon who has pioneered minimally invasive techniques in this field and developed new procedures for Eustachian tube disorders. His research activities focus on otitis media and novel therapies for sensorineural hearing loss. He is investigating the inflammatory basis of Eustachian tube dysfunction and doing research in collaboration with the University of Tampere, Finland and the NanoEar European Union consortium on nanotechnology for targeted delivery of inner ear and middle ear therapy.
Script embedded in HTML
Content copyright 2021. entratympanic.com. All rights reserved.
